Synthetic Biologics Inc SYN Balance Sheet

Income Statement

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	78.7M	71.86M	67.89M	65.45M	61.55M	55.22M	48.73M	42.39M
Total Current Assets	52.73M	45.52M	40.3M	37.97M	34.77M	27.4M	21.66M	19.72M
Cash and Equivalents	50.49M	41.79M	36.08M	34.25M	31.16M	23.18M	18.26M	16.59M
Total Non-Current Assets	26.23M	26.69M	27.91M	27.79M	27.17M	28.24M	27.45M	23.01M
Total Liabilities	20.55M	17.3M	17.3M	17.7M	17.66M	15.52M	14.61M	14.74M
Total Current Liabilities	13.19M	7.06M	8.62M	9.13M	8.74M	6.74M	6.01M	6.85M
Total Non-Current Liabilities	7.56M	10.46M	8.84M	8.72M	9.07M	8.95M	8.76M	7.99M
Common Equity	16k	16k	16k	18k	18k	18k	18k	23k
Retained Earnings	-285.38M	-290.97M	-295.45M	-300.53M	-303.83M	-309.32M	-314.48M	-322.8M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	22.5M	18.84M	30.14M	17.24M	8.41M	70.37M	71.86M	55.22M
Total Current Assets	21.57M	17.94M	29.51M	16.43M	7.93M	68.86M	45.52M	27.4M
Cash and Equivalents	19.06M	17.12M	28.92M	15.05M	6.23M	67.33M	41.79M	23.18M
Total Non-Current Assets	2.25M	-3.41M	14.16M	-1.06M	-7.54M	65.41M	51.83M	36.96M
Total Liabilities	20.25M	22.25M	3.69M	5.75M	3.15M	4.96M	17.3M	15.52M
Total Current Liabilities	19.76M	9.79M	3.38M	5.28M	2.97M	3.55M	7.06M	6.74M
Total Non-Current Liabilities	492k	12.46M	302k	473k	186k	1.4M	10.46M	8.95M
Total Equity	2.25M	-3.41M	14.16M	-1.06M	-7.54M	65.41M	51.83M	36.96M
Common Equity	117k	129k	5.78M	4.78M	2.51M	132k	16k	18k
Retained Earnings	-172.03M	-194.17M	-219.46M	-235.54M	-248.09M	-271.28M	-290.97M	-309.32M